Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.4380
-0.0143 (-3.16%)
At close: Oct 29, 2026, 4:00 PM EDT
0.4375
-0.0005 (-0.11%)
Pre-market: Oct 30, 2026, 5:59 AM EDT
Ensysce Biosciences Stock Forecast
ENSC's stock price has decreased by -79.24% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 2 analysts polled by S&P Global, Ensysce Biosciences stock has an average price target of $5.13. The average 1-year stock price forecast is 1,070.09% higher than the current stock price, while the lowest is $2.00 (+356.62%) and the highest is $8.25 (+1,783.56%).
Price Target: $5.13 (+1,070.09%)
Analyst Consensus: n/a
Price Target
ChartAnalyst Ratings
According to 1 stock analyst, the rating for Ensysce Biosciences is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | May '26 | Jul '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0 | 0 | 0 | 0 | 0 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $2 | Buy | Initiates | $2 | +356.62% | Oct 20, 2026 |
Financial Forecast
Revenue This Year
4.50M
from 5.07M
Decreased by -11.18%
Revenue Next Year
3.00M
from 4.50M
Decreased by -33.33%
EPS This Year
-2.23
EPS Next Year
-0.05
from -2.23
EPS and Forward PE are based on non-GAAP adjusted numbers.